NewGenIVF Group Limited has issued 3,666,667 new shares as part of its strategic acquisition of a 10% equity interest in K25.ai, bringing total outstanding shares to 10,073,535 and pushing market capitalization to US$7,631,710 as of June 18, 2026. Management notes this market cap represents a substantial discount to the company’s net asset value of approximately US$25.98 million as of December 31, 2025, and the balance sheet has been further strengthened by a subsequent US$10 million investment in K25.ai. The company believes the increased capitalization positions it to meet Nasdaq’s proposed minimum Market Value of Listed Securities threshold of US$5 million. The K25.ai transaction is part of NewGen’s strategic pivot toward AI, digital engagement, and prediction markets across permitted APAC jurisdictions. Founder and CEO Alfred Siu Wing Fung highlighted the meaningful upside potential given the gap between market cap and net asset value.
NewGenIvf Group Limited Class A Ordinary SharesIssued shares for K25.ai stake, market cap discount to NAV, and $10M investment strengthen balance sheet and Nasdaq compliance.
NewGen's acquisition of 10% stake and $10M investment in K25.ai provides capital and strategic backing.